Ascend Wellness Holdings, Inc.

OTCPK:AAWH Stock Report

Market Cap: US$100.8m

Ascend Wellness Holdings Valuation

Is AAWH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AAWH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AAWH ($0.47) is trading below our estimate of fair value ($3.17)

Significantly Below Fair Value: AAWH is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AAWH?

Key metric: As AAWH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AAWH. This is calculated by dividing AAWH's market cap by their current revenue.
What is AAWH's PS Ratio?
PS Ratio0.2x
SalesUS$565.75m
Market CapUS$100.78m

Price to Sales Ratio vs Peers

How does AAWH's PS Ratio compare to its peers?

The above table shows the PS ratio for AAWH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average14x
ZHYB.F Zhong Yuan Bio-Technology Holdings
35.4xn/aUS$88.3m
FTLF FitLife Brands
2.3x9.2%US$143.0m
DSY Big Tree Cloud Holdings
17.7xn/aUS$141.0m
SKIN Beauty Health
0.6x5.7%US$200.5m
AAWH Ascend Wellness Holdings
0.2x3.2%US$100.8m

Price-To-Sales vs Peers: AAWH is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (14x).


Price to Sales Ratio vs Industry

How does AAWH's PS Ratio compare vs other companies in the US Personal Products Industry?

29 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.1.0x4.7%
AAWH Ascend Wellness Holdings
0.2x3.2%US$100.78m
HLF Herbalife
0.2x1.8%US$778.11m
NUS Nu Skin Enterprises
0.2x-0.06%US$377.31m
AAWH 0.2xIndustry Avg. 1.0xNo. of Companies28PS02.44.87.29.612+
29 CompaniesEstimated GrowthMarket Cap
Industry Avg.1.0x25.5%
AAWH Ascend Wellness Holdings
0.2x83.1%US$100.78m
No more companies

Price-To-Sales vs Industry: AAWH is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Personal Products industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is AAWH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AAWH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.6x

Price-To-Sales vs Fair Ratio: AAWH is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AAWH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$0.47
US$2.44
+425.3%
34.3%US$4.00US$1.25n/a7
Nov ’25US$0.86
US$3.18
+270.5%
25.8%US$5.00US$2.50n/a7
Oct ’25US$0.80
US$3.16
+294.5%
24.4%US$5.00US$2.50n/a8
Sep ’25US$0.96
US$3.16
+229.4%
24.4%US$5.00US$2.50n/a8
Aug ’25US$1.09
US$3.53
+225.5%
30.1%US$6.00US$2.50n/a8
Jul ’25US$0.91
US$3.46
+280.0%
25.9%US$5.00US$2.50n/a6
Jun ’25US$1.07
US$3.46
+223.8%
23.9%US$5.00US$2.50n/a7
May ’25US$1.26
US$3.41
+170.3%
23.2%US$5.00US$2.50n/a8
Apr ’25US$1.33
US$3.41
+156.1%
23.2%US$5.00US$2.50n/a8
Mar ’25US$1.44
US$3.34
+132.2%
26.2%US$5.00US$2.00n/a8
Feb ’25US$1.55
US$3.34
+115.7%
26.2%US$5.00US$2.00n/a8
Jan ’25US$1.00
US$3.34
+234.4%
26.2%US$5.00US$2.00n/a8
Dec ’24US$1.32
US$3.34
+153.0%
26.2%US$5.00US$2.00n/a8
Nov ’24US$0.92
US$3.64
+296.7%
27.1%US$5.00US$2.00US$0.868
Oct ’24US$0.94
US$3.51
+273.7%
24.5%US$4.75US$2.00US$0.808
Sep ’24US$0.78
US$3.51
+350.6%
24.5%US$4.75US$2.00US$0.968
Aug ’24US$0.62
US$4.07
+554.3%
33.7%US$6.25US$1.75US$1.099
Jul ’24US$0.62
US$4.08
+557.3%
35.7%US$6.25US$1.75US$0.918
Jun ’24US$0.78
US$4.08
+422.4%
35.7%US$6.25US$1.75US$1.078
May ’24US$0.98
US$4.20
+329.7%
30.5%US$6.25US$2.75US$1.268
Apr ’24US$0.94
US$3.94
+317.0%
32.9%US$6.25US$1.75US$1.3311
Mar ’24US$1.17
US$5.35
+357.3%
40.3%US$9.50US$1.75US$1.4411
Feb ’24US$1.40
US$5.83
+316.1%
31.6%US$9.50US$2.75US$1.5510
Jan ’24US$1.15
US$6.15
+434.8%
30.7%US$9.50US$2.75US$1.0010
Dec ’23US$2.03
US$6.38
+214.0%
24.8%US$9.50US$4.00US$1.3210
Nov ’23US$2.12
US$6.58
+210.1%
29.4%US$10.00US$4.00US$0.9210

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies